LILRB1 and endometriosis: On the other hand, due to the upregulated expression of the inhibitory receptors observed in endometriosis, the inhibition of KIR2DL1, LILRB1/2, and NKG2A by monoclonal antibodies may have therapeutic effects on endometriosis (183).